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Antimicrobial materials have become a relevant for local therapies preventing microbial 
resistance induced by systemic antibiotic treatments. This work reports the development of 
electrospun PLLA nanofiber membranes loaded with bovine lactoferrin (bLF) up to 20 wt%. 
The membranes presented smooth and non-defective fibers with mean diameters between 717 
± 197 and 495 ± 127 nm, and an overall porosity of ≈ 80 %. The hydrophobicity of the PLLA 
membranes was reduced by the presence of bLF. The release profile of bLF correlates with an 
anomalous transport model, with 17.7 ± 3.6 % being released over 7 weeks. The nanofiber 
mats showed no cytotoxicity on human skin fibroblasts and even promoted cell proliferation 
after short exposure periods. Furthermore, the developed membranes displayed antifungal 
activity against A. nidulans by inhibiting spore germination and mycelial growth. These 
results evidence the strong potential of bLF-PLLA nanofiber membranes to be used as 
antifungal dressings. 
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1. Introduction 
The high incidence of infection by antibiotic-resistant bacteria is a growing health concern 
worldwide. In Europe alone, it is estimated to cause 25000 fatalities each year accounting for 
1.5 billion euros spent annually [1]. Therefore, novel strategies to manage infection and avoid 
emergence of resistance during therapy, mainly through prophylactic approaches using 
antimicrobial coatings or dressings in medical devices [2]. For instance, topical antimicrobial 
therapy may be especially helpful in the treatment of skin wounds, where a local approach 
would be more effective in avoiding healing delays or progression to a systemic infection [3, 4]. 
Ionic silver is the most studied antimicrobial agent with a far lower propensity for resistance 
development than antibiotics [5]. Currently, silver-based formulations are used to inhibit 
bacterial growth in several medical applications, such as functionalization of catheters, dental 
practice, coating of medical devices, in cosmetics and as wound dressings for open infected 
wounds, skin ulcers, compound fractures, and burn injuries [5-7]. However, the possible side 
effects related to long-term exposure to silver nanoparticles [8-11] justify the quest for new 
biocompatible molecules that can be metabolized, thus avoiding cytotoxicity [12]. 
Lactoferrin (LF), an 80 kDa iron-binding glycoprotein of the transferrin family, is a major 
component of milk and can be found in the secondary granules of neutrophils, in mucosal 
surfaces and in biological fluids of different mammals, playing an important role in the innate 
immune response [12-14]. Amongst its physiological roles, including iron homeostasis, immune 
response, antioxidant, anticancer and anti-inflammatory properties, the antimicrobial activity 
is the most studied [14-16]. LF is active against a broad spectrum of Gram-positive [17, 18] and 
Gram-negative [19, 20] bacteria, fungi [21, 22], viruses [23, 24] and protozoa [25]. This activity is 
based on the ability to sequester iron, an essential nutrient for pathogens, or by direct 
interaction with the microorganisms [26]; thus, structural integrity under processing is essential 
for keeping its bioactivity. 
https://onlinelibrary.wiley.com/doi/pdf/10.1002/mabi.201700324 
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Electrospinning is a versatile and inexpensive polymer processing technique used to produce 
continuous nanostructured fibrous materials [27]. This approach allows the processing of many 
polymers as well as composites for a wide set of applications, including biomedical scaffolds 
[28] which may have incorporated functional proteins or peptides [29] for additional functions.  
Poly(lactic acid) (PLLA) is a bio-based, biodegradable polymer derived from renewable 
resources such as starch from corn or potato [30]. Being classified as GRAS (Generally 
Recognized As Safe) by the FDA (Food and Drug Administration), this is a very attractive 
polymer for the pharmaceutical and biomedical industries due to its biocompatibility and 
biodegradability [31]. Additionally, PLLA is easily processed by several techniques, including 
electrospinning, enabling the tuning of its physico-chemical and biological properties [32-35].  
In view of the above mentioned, the aim of this work was to evaluate the feasibility of 
developing composite PLLA-bovine lactoferrin (bLF) membranes by electrospinning, as a 
promising new alternative to conventional antimicrobial wound dressings. The processing 
effects were assessed by a thorough physical-chemical characterization of the composites with 
the bLF release profile also being evaluated. The cytotoxicity of the electrospun fiber mats 
was assessed using human fibroblasts and the antimicrobial activity evaluated against 
Pseudomonas aeruginosa, Staphylococcus aureus and Aspergillus nidulans. 
 
2. Experimental Section 
2.1. Materials 
Purasorb PL18 (PLLA), with an average molecular weight of 217,000 – 225,000 g.mol-1, was 
purchased from Purac, bovine lactoferrin (bLF) was obtained from DMV International (USA) 
with a reported composition of 96 wt% dry weigh of protein, approximately 120 ppm of iron, 
0.5 wt% of ash and 3.5 wt% of moisture. Dimethylformamide (DMF) and dichloromethane 
https://onlinelibrary.wiley.com/doi/pdf/10.1002/mabi.201700324 
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(DCM) of analytical grade were purchased from Sigma-Aldrich. All materials and chemicals 
were used as received. 
 
2.2. Solution Preparation 
PLLA solution was prepared according to the method reported elsewhere [35]. For the 
composite samples, PLLA at a concentration of 10 wt% was dissolved in DMF/DCM (30/70, 
v/v) mixture, and the desired amount of bLF (0, 10 and 20 wt%, related to the polymer 
content) was added to the solution and placed in an ultrasound bath for 60 min for better 
dispersion of protein in the polymer solution. 
 
2.3. Electrospinning 
The polymer solution was transferred to a plastic syringe fitted with a steel needle with a 
diameter of 0.5 mm. Electrospinning was conducted with an electric field between 0.75 and 
1.5 kV.cm-1, applied with a high voltage power supply from Gamma High Voltage Research. 
A syringe pump (KDS 100L Pump from KDScientific) was used to feed the polymer 
solutions into the needle tip at a rate of 0.5 ml.h-1. The electrospun fibers were collected in 
grounded collecting plates (random fibers) placed at 15 cm from the needle. 
 
2.4. Characterization of the Nanofiber Membranes 
Samples were coated with a thin gold layer using a sputter coating (Smart Coater, JEOL) and 
their morphology was analyzed using a scanning electron microscopy (JEOL JSM-6490LV) 
with an accelerating voltage of 5 kV. The nanofibers average diameter and their distribution 
was calculated with at least 50 randomly selected fibers from SEM micrographs (5,000 X 
magnification), using ImageJ image processing software [36].  
Infrared measurements (FTIR) were performed at room temperature in a Spectrum Two™ IR 
spectrometer (Perkin Elmer) in ATR mode (UATR accessory, Perkin Elmer). Spectra were 
https://onlinelibrary.wiley.com/doi/pdf/10.1002/mabi.201700324 
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collected after 64 scans with a resolution of 4 cm-1 from 4000 to 400 cm-1. Normalization and 
spectra representation were performed with OriginPro 9.0 (OriginLab, Northampton, MA). 
The thermal behavior of the electrospun fiber mats was analyzed by differential scanning 
calorimetry measurements (DSC) with a TA Q100 apparatus (TA instruments). The samples 
were cut into small pieces from the middle region of the electrospun membranes and placed 
into 30 µl aluminum pans and heated between 30 and 200 ºC at a heating rate of 10 ºC.min-1. 
All experiments were performed under a nitrogen purge. The thermal degradation kinetics 
was characterized by means of thermogravimetric analysis (TGA) in a TA Q500 (TA 
instruments), using different heating rates (10, 20, 30 and 40 °C.min-1). All experiments were 
performed under argon atmosphere. 
Water contact angle measurements (WCA, sessile drop in dynamic mode) were performed at 
room temperature in a Data Physics OCA20 device using ultrapure water as test liquid. The 
contact angles were measured by depositing water drops (3 µL) on sample surface and 
analyzed with SCA20 software. At least 6 measurements were performed for each sample and 
in different locations, and the average contact angle was taken as the result for each sample. 
Overall membrane porosity was determined by the pycnometer method following the 
procedure described elsewhere [37, 38]. Briefly, the weight of the pycnometer filled with 
ethanol was measured and labeled as 𝑊1; the sample with weight 𝑊𝑠 was immersed in 
ethanol. Subsequently, the sample was saturated by ethanol; additional ethanol was added to 
complete the volume of the pycnometer. Then, the pycnometer was weighted and labeled as 
𝑊2; the sample filled with ethanol was taken out of the pycnometer and the residual weight of 
the ethanol and the pycnometer was labeled as 𝑊3. The porosity of the membrane was 
calculated according to Equation 1. The mean porosity of each membrane was obtained as 
the average of the values determined in three samples. 
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𝜀 =
𝑊2 −𝑊3 −𝑊𝑠
𝑊1 −𝑊3
 
(1) 
 
2.5. In Vitro Release of Lactoferrin and Hydrolytic Degradation 
The in vitro release profile of the lactoferrin from 20 wt% bLF-PLLA membranes was 
determined under sink conditions. Membrane disks (∅ = 19 𝑚𝑚) were weighted (𝑀1) and 
placed in vessels containing 5 ml of PBS buffer (8 g.L-1 NaCl, 0.2 g.L-1 KCl, 1.44 g.L-1 
Na2HPO4, 0.24 g.L-1 KH2PO4, pH 7.4) and incubated at 37 ºC. At predetermined time points, 
the disks were removed, rinsed with ddH2O to remove the salts, and then dried under low 
pressure in a vacuum chamber (VACUO-TEMP, JP Selecta, Spain). After final weight 
determination (𝑀2), hydrolytic degradation was calculated by Equation 2. The release 
medium was measured at λmax 280 nm using a UV-Vis spectrophotometer (Shimadzu 
UV1800, Japan). Protein concentration was calculated using a standard curve (Equation 3) of 
bLF in PBS (pH 7.4). The release profile of bLF was calculated according to Equation 4.  
𝑀𝑀𝑀𝑀 𝑙𝑙𝑀𝑀 (%) = �1 −
𝑀2
𝑀1
� × 100 (2) 
𝑂𝑂280𝑛𝑛 = 0.9778𝑥 + 0.01399 (𝑅2 = 0.998) (3) 
𝑏𝑏𝑏 𝑟𝑟𝑙𝑟𝑀𝑀𝑟 (%) =
𝑀𝑚𝑙𝑎𝑎𝑎 𝑙𝑜 𝑏𝑏𝑏 𝑟𝑟𝑙𝑟𝑀𝑀𝑟𝑟 𝑀𝑎 𝑎𝑡𝑚𝑟 𝑎
𝑎ℎ𝑟𝑙𝑟𝑟𝑎𝑡𝑒𝑀𝑙 𝑀𝑚𝑙𝑎𝑎𝑎 𝑙𝑜 𝑏𝑏𝑏 𝑡𝑎 𝑎ℎ𝑟 𝑚𝑟𝑚𝑏𝑟𝑀𝑎𝑟
× 100 (4) 
 
2.6. Release Kinetics Models 
https://onlinelibrary.wiley.com/doi/pdf/10.1002/mabi.201700324 
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bLF release results were fitted to the mathematical models to further study the protein release 
kinetics from the composite membranes. The best fit was achieved by the Korsmeyer-Peppas 
model (Equation 5): 
𝑀𝑡
𝑀∞
= 𝐾𝑎𝑛 (5) 
Where 𝑀𝑡
𝑀∞
 is a fraction of drug released at time 𝑎, 𝐾 is the rate constant, and 𝑎 is the exponent 
that characterizes the release mechanism [39, 40]. 
 
2.7. Membrane Sterilization for Biological Assays 
The membranes were cut either in disks (antibacterial assays) or squares (antifungal assays) of 
adequate diameters and sterilized by UV exposure (λ = 254 nm) for 30 minutes (15 minutes 
each side).  
 
2.8. Cell Culture and Cytotoxicity Evaluation 
Telomerase-immortalized normal human skin fibroblasts (BJ-5ta cell line) were obtained 
from the American Type Culture Collection (ATCC) through LGC standards and cultured in 
humidified environment at 37 ºC, 5 % CO2, according to ATCC recommendations (BJ-5ta 
medium – 4 parts of Dulbecco’s modified Eagle’s medium containing 4 mM L-glutamine, 4.5 
g/L glucose, 1.5 g/L sodium bicarbonate, and 1 part of Medium 199, supplemented with 10 % 
(v/v) of foetal bovine serum (FBS), 1 % (v/v) penicillin/streptomycin solution and 10 µg/mL 
hygromycin B). 
Cell viability in response to short-term contact with the bLF-PLLA composites was assessed 
by MTS assay (CellTiter 96® Aqueous One Solution Cell Proliferation, Promega) according 
to manufacturer’s instructions. UV sterilized samples of 100 mm2 were incubated with 750 μl 
of cell culture medium without FBS for 24 h at 37 ºC, 5 % CO2 in humidified environment. 
https://onlinelibrary.wiley.com/doi/pdf/10.1002/mabi.201700324 
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At the same time, 100 μl of BJ-5ta cell suspension (6.6 x 104 cells/mL) were seeded and 
cultured in surface treated 96-well plates (Nunclon polystyrene 96-well MicroWell, Thermo 
Scientific) for 24 h according to the cell culture conditions described above. After the 
incubation time, the cell culture medium was removed and replaced with the medium 
conditioned by contact with the bLF-PLLA membranes. Cells were incubated for an 
additional 24 and 72 h at 37 ºC, 5 % CO2, in humidified environment after which cell viability 
was measured using the MTS proliferation assay. Briefly, cells in 1x sterile PBS were 
incubated with MTS solution for 2 h at 37 ºC followed by reading the absorbance at 490 nm 
using standard PBS as blank measurement. Live cells react with tetrazolium salt in the MTS 
reagent producing a soluble formazan dye, which has absorbance at a wavelength of 490 nm. 
In the linear range of the absorbance curve, the absorbance intensity is proportional to the 
number of metabolically active cells. Cells cultured in standard culture and in 30 % DMSO 
were used as positive and negative controls for cell viability, respectively. Results were 
expressed as percentage of viability related to the positive control (set as 100 % viability). All 
the experiments were performed in triplicate. 
 
2.9. In Vitro Antibacterial and Antifungal Properties of bLF-PLLA Membranes 
Antibacterial assays were performed by the agar diffusion method with cultures of 
Pseudomonas aeruginosa ATCC 10145 and Staphylococcus aureus ATCC 6538 grown in LB 
medium (yeast extract 5 g.L-1, sodium chloride 5 g.L-1, Tryptone 10 g.L-1). Overnight cultures 
of the testing microorganisms were diluted in LB-Agar (0.8 % w/v) to a final density of 
1 × 106 CFUs/mL and layered on LB Agar (1.5 % w/v) plates. Pre-sterilized bLF-PLLA 
disks (∅ = 5 mm) were placed in contact with the plate top-layer surface and incubated 
overnight at 37 ºC. Controls were performed using cellulose diffusion disks (Oxoid) and 
Kanamycin disks (30 µg, BD Biosciences) as negative (C-) and positive (C+) controls for 
https://onlinelibrary.wiley.com/doi/pdf/10.1002/mabi.201700324 
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growth inhibition, respectively. After the incubation period, the diameters of growth 
inhibitory zones were evaluated. 
Antifungal activity against Aspergillus nidulans was assessed by a modified spore 
germination assay as described before [41]. Briefly, spores were collected with the help of a 
sterile toothpick and inoculated in complete potato dextrose agar medium (PDA, BD 
Difco™). Square samples of bLF-PLLA with an area of 100 mm2 were placed over the spore 
inoculation sites and incubated for 72 h at 37 ºC. Digital images were recorded with a 
Chemidoc XRS System (BioRad) and the mycelial growth was measured and analyzed by 
ImageJ software. Cellulose disks embedded with itraconazol (25 mg.mL-1) were used as 
positive control for growth inhibition. Additional antifungal assays involved evaluating the 
ability of the bLF-PLLA membranes to inhibit spore germination by scanning electron 
microscopy (SEM). Spores of A. nidulans were inoculated in complete medium (CM, salt 
solution 20 mL, vitamin solution 10 mL, casamino acids 1 g, yeast extract 1 g, peptone 2 g, 
glucose 10 g, per liter at pH 6.8) and placed in contact with the bLF-PLLA membranes 
followed by incubation at 37 ºC for 18 h. For fixation, the samples were soaked in a 
glutaraldehyde solution in PBS (1 mL of 2.5 % v/v in PBS) for 1 h at room temperature (RT), 
rinsed with 1 mL of distilled water and dehydrated by immersion for 30 min in a series of 
successive ethanol/water solutions (0.5 mL of 55, 70, 80, 90, 95 and 100 % v/v). Samples 
were dried at RT and coated with a thin Au/Pd layer and analyzed by scanning electron 
microscopy (SEM, NanoSEM – FEI Nova 200) with a 5.0 kV voltage and a through-lens 
detector (TLD).  
 
2.10. Statistics and Data Analysis 
One-way analysis of variance (ANOVA) with Bonferroni’s post-test was carried out to 
compare the means of different data sets within each experiment using GraphPad Prism 5 
https://onlinelibrary.wiley.com/doi/pdf/10.1002/mabi.201700324 
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software. A value of p < 0.05 was considered statistically significant. All experiments were 
performed in triplicate. 
 
3. Results and Discussion  
3.1. Fabrication and Characterization of the Electrospun Nanofiber Membranes 
Electrospinning processing parameters deeply influence the fiber morphology and properties 
of the membranes, including initial polymer solution (polymer concentration and molecular 
weight, solvent boiling point, electrical permittivity or dipole moment), control of jet 
formation and solvent evaporation kinetics (flow rate, temperature, moisture, needle inner 
diameter, applied electric field), and collecting procedure (random or aligned fibers) [42, 43]. 
One of the requirements for the formation of uniform fibers is the formation of a stable Taylor 
cone so, initial electrospinning experiments involved the determination of the optimal 
parameters to process PLLA (Table S1). Optimal conditions were found by applying an 
electric field of 1.0 kV.cm-1, a flow rate of 0.5 mL.min-1, a needle inner diameter of 0.5 mm 
and a polymer concentration of 10 % (w/v). Therefore, these conditions were kept constant 
throughout all the experiments to study the influence of the bLF amount on the fiber average 
diameter and size distribution. 
Smooth and non-defective fibers (Figure 1) were obtained from the PLLA polymer solution 
under the electrospinning conditions stated in Table S1. When bovine lactoferrin was added to 
the polymer solution, the electrospinning parameters showed to be equally optimal with a 
stable jet identical to that of the pristine PLLA. For all samples, the produced fibers were 
randomly distributed and non-defective with a smooth surface. Addition of bLF to the 
polymer solution led to a decrease in mean fiber diameter and a narrower size distribution for 
the sample with 20 wt% of bLF, which is probably related to the increase in conductivity 
promoted by the filler protein (Figure 1). Despite the reduction in the average fiber diameter, 
https://onlinelibrary.wiley.com/doi/pdf/10.1002/mabi.201700324 
 
 
 - 12 - 
the overall porosity (calculated by Equation 1) of the different samples was not significantly 
affected by the incorporation of bLF, reaching values of 79 ± 3 %, 78 ± 3 % and 80 ± 4 %, for 
PLLA, 10 % bLF and 20 % bLF, respectively. 
Wettability of the electrospun samples was measured through water contact angle and it was 
observed that neat PLLA had the strongest hydrophobic behavior with a WCA of 130 ± 2º. 
This value was slightly reduced with the presence of bLF in the membranes, reaching a value 
of 122 ± 1º for the sample with 20 wt% of bLF (Figure 1d). Kim et al. [44] also reported that 
the WCA of titanium substrate decreases when human milk LF is immobilized on its surface, 
due to the affinity of the water molecules with the amide groups present in the bLF structure.  
The infrared spectrum of pure PLLA, bLF and bLF-PLLA electrospun membranes is depicted 
in Figure 2. The characteristic absorption bands of PLLA were observed both for the pristine 
and for the composite membranes at around 955 cm-1, 1183 cm-1, 1455 cm-1, 1757 cm-1 and 
2945 cm-1, which are related to the amorphous phase [32]. The characteristic protein absorption 
bands of amide I (1700-1600 cm-1, C=O stretching vibration) centered around 1641 cm-1 and 
of amide II (1600-1500 cm-1, N-H bending with contribution of C-N stretching vibrations) 
centered around 1529 cm-1 were observed for the pure bLF, although at a lower intensity, for 
the bLF-PLLA composites [45]. The lower intensity of the amide I and amide II bands 
observed for the bLF-PLLA composites is attributed to the low amount of bLF within the 
fibers. Nevertheless, normalization of truncated amide I and amide II band regions allowed to 
confirm the presence of these bands in the FTIR spectra (Figure 2b). By comparing the 
spectra, it is possible to observe the absence of shifts in peak positions or the presence of new 
vibrational modes in the composites, other than those attributed to the amide bands. This 
demonstrates that both PLLA and bLF do not suffer structural changes during electrospinning 
and that there are no chemical reactions between bLF and PLLA. 
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3.2. Thermal Properties 
During electrospinning, much of the solvent present in the stretched jet is evaporated between 
the needle tip and the grounded collector. The fast solvent evaporation kinetics often results in 
a metastable phase [46]. Differential scanning calorimetry (Figure 3) was performed in the 
PLLA and bLF-PLLA electrospun samples to infer the influence of the filler in the thermal 
properties of the matrix. It was observed that incorporation of 10 wt% of bLF does not 
significantly change the glass transition (𝑇𝑔 = 57 °𝐶) or the cold-crystallization temperature 
(𝑇𝑐𝑐 = 86 °𝐶). However, for the sample with 20 wt% of bLF, the cold-crystallization process 
is suppressed by the denaturation of the bLF that occurs at temperatures between 52 – 89 °C 
[47]. The melting temperature of the polymer matrix was not affected by addition of bLF 
reaching its maximum at approximately 154 °C (table S2), which is in accordance to the 
melting values reported for PLLA [30, 33, 35]. 
Thermogravimetric analysis was used to study the degradation kinetics of pure bLF, PLLA 
and bLF-PLLA nanocomposite membranes (Figure 4). The thermogram of pure bLF reveals 
an initial weight loss of about 8 wt% at temperatures up to 120 ºC and is attributed to the loss 
of moisture, likely due to sample handling and storage conditions, followed by a strong mass 
loss at temperatures above 200 °C attributed to the decomposition of the protein [48]. 
Regarding the PLLA matrix, the thermogram does not present any dehydration process, which 
agrees with the hydrophobic behavior found through WCA (Figure 1d), and is dominated by a 
single stage of major weight loss between 300 and 400 °C, attributed to the thermal 
decomposition of the polymer. When bLF was added to the PLLA electrospun fibers, the 
absence of adsorbed water was noticed for all nanocomposite samples, suggesting that the 
filler is randomly distributed throughout the core of the PLLA fibers, rather than be 
concentrated on the surface of the polymer fibers; this is in accordance to the results reported 
in Figure 1d, where the WCA did not decrease significantly with the presence of the 
lactoferrin in the PLLA electrospun fibers. The presence of bLF in the polymeric electrospun 
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fibers also led to a slight decrease of the thermal stability of the polymer matrix (table S3). 
Nevertheless, the residual mass increases with the amount of the filler added to the polymeric 
fiber matrix. 
The kinetics of the mass loss were studied through the analysis of the TGA experiments and 
by applying the Kissinger mathematical model [49]: 
  
ln�
𝛽
𝑇𝑝2
� =
ln(𝐴𝐸𝑎𝑐𝑡)
𝑇𝑝
+ 𝑙𝑎�𝑎�1 − 𝛼𝑝�
𝑛
� −
𝐸𝑎𝑐𝑡
𝑅𝑇𝑝
 
(7) 
where, 𝛽 is the experimental heating rate, 𝑇𝑝 and 𝛼𝑝 are the absolute temperature and the 
conversion at the maximum mass loss rate, and 𝐸𝑎𝑐𝑡 and 𝑅, are the thermal decomposition 
activation energy and the ideal gas constant, respectively. 
According to the Kissinger’s model for the degradation kinetics, the slope of the dot lines is 
proportional to the 𝐸𝑎𝑐𝑡 (Figure 4c). When bLF is added to the PLLA fiber matrix, there is an 
increase of the thermal decomposition activation energy to values close to those calculated for 
pure free bLF (Figure 4d). 
 
3.3. In Vitro Release of bLF 
The hydrolytic degradation and release profiles of PLLA and 20 wt% bLF-PLLA composites 
was performed in a PBS solution at 37 °C (Figure 5). Hydrolytic degradation of PLLA is a 
slow process and almost no mass loss was observed for the neat PLLA membrane over 7 
weeks of experiment, while a decrease in sample weight of 2.7 ± 0.5% was detected for the 
bLF-PLLA membranes, suggesting that only a small amount of bLF is present on the surface 
of the PLLA electrospun fibers, while the main amount is dispersed in the core of the 
polymeric fiber (Figure 5a). 
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During the in vitro degradation assays, the release of the bLF was also monitored (Figure 5b). 
The electrospun composites showed an initial release of bLF of 8.0 ± 4.5 % during the first 7 
days, followed by a gradual release over ∼7 weeks, of up to 17.7 ± 4.4 %. The release profile 
was fitted with the Korsmeyer-Peppas model (Figure 5b), and a release exponent of 𝑎 = 0.51 
was calculated, suggesting that the release of the bLF through the PLLA fibers is governed by 
an anomalous transport [39, 40, 50], which was defined as a superposition of two apparently 
independent mechanisms of drug transport, a Fickian diffusion process and a case-II transport 
[40]. Accordingly, the initial boost of the bLF release to the PBS medium is due to the presence 
of the filler on the surface of the PLLA fiber, as it can be deduced from the evolution of mass 
loss (Figure 5a), while the gradual release after week 7 is possibly due to swelling of the 
PLLA promoted by diffusion of the PBS solution through the core of the polymeric fiber, 
allowing a steady release of bLF. 
 
3.4. Cytotoxicity Assays 
Cell viability of human skin fibroblasts (BJ-5ta cell line) in response to the bLF-PLLA 
composite membranes was assessed by indirect contact for 24 and 72 h using the MTS assay 
(Figure 6). After 24 h of incubation, no statistically significant differences were observed 
between the control (100.0 ± 2.8 %) and 0 wt% bLF-PLLA (92.7 ± 12.5 %) or 10 wt% bLF-
PLLA (102.8 ± 4.7 %). Interestingly, the 20 wt% bLF-PLLA composite could induce a slight 
but significant proliferative effect in BJ-5ta cells, showing values of 109.3 ± 6.2 % of cell 
viability. Similarly, after 72 h of incubation, no significant cytotoxicity was observed for the 
produced materials, apart from the 20 wt% bLF-PLA composite which lead to a slight 
decrease in cell proliferation to about 88.9 ± 8.8 %. Overall, these results confirm the 
cytocompatibility of the developed composite membranes, a key pre-requisite when 
developing biomedical devices.  
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3.5. In Vitro Antimicrobial Properties of bLF-PLLA Membranes 
The antibacterial activity of the electrospun bLF-PLLA membranes was assessed for P. 
aeruginosa and S. aureus by agar disk-diffusion method (Figure 7a). In opposition to the 
positive control and similarly to the PLLA electrospun fibers (0 wt% bLF-PLLA), no 
significant inhibition halos were found for either bacteria. As the occurrence of fungal 
infections in human skin and mucosa is growing, it fuels a growing demand for new 
antifungal strategies. Therefore, the antimicrobial studies were further extended to 
filamentous fungi by assessing the ability of the composite membranes to inhibit spore 
germination (Figure 7b) and mycelial growth (Figure 7c) of A. nidulans. Evaluation of the 
sporicidal activity was conducted by placing spores of A. nidulans in direct contact with the 
electrospun fibers, followed by SEM analysis. SEM micrographs reveal that inhibition of 
spore germination was dependent of lactoferrin content, with complete inhibition observed 
with the 20 wt% composite (Figure 7b). Indeed, while complete germination was observed 
with the PLLA sample (0 wt% bLF-PLLA), this process showed to be limited or even absent 
in the samples containing 10 wt% and 20 wt% bLF, respectively. Considering these results, 
the ability of the composites to inhibit mycelial growth was tested using 20 wt% bLF-PLLA 
as a representative sample (Figure 7c). Although displaying a modest activity, the electrospun 
membrane could significantly inhibit mycelium growth when compared to the PLLA sample 
(0 wt% bLF-PLLA) or to the control (direct inoculation with no sample) (Figure 7c).  
The antimicrobial effect of bLF has been widely reported for an extensive range of pathogens, 
including those studied in this work [51], [52] and [22] (Aspergillus spp.). The lack of 
antibacterial activity observed in the disk diffusion assay and even the modest inhibition of 
mycelium growth may be explained by the slow release rate of bLF from the membranes 
(Figure 5b). For instance, only about 8 % is released after 7 days of immersion in PBS. 
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Furthermore, considering that water availability is considerable lower in the agar plate than in 
the in vitro release assay, then bLF concentration was probably negligible during the time of 
the experiment. This is further supported by the spore germination assay in which spores of A. 
nidulans were placed in direct contact with the fibers and thus exposed to a higher amount of 
bLF. Future strategies to overcome these limitations include the development of composites 
with higher bLF content and fibers’ surface decoration with bLF after plasma treatment. 
Nevertheless, the positive results regarding the antifungal activity reinforce the potential use 
of these composites in biomedical applications, such as wound dressings. 
4. Conclusions 
This work reports the successful immobilization of a bioactive protein – bovine lactoferrin – 
in PLLA fiber membranes produced by electrospinning. The immobilization of bLF resulted 
in a decrease of the average fiber diameter from 717 ± 197 nm for pristine PLLA, down to 
495 ± 127 nm for the sample with 20 wt% bLF. Moreover, a decrease in wettability was also 
noticed for the nanocomposite membranes. The produced bLF-PLLA membranes did not 
induce cytotoxicity on human fibroblasts and noteworthy, the 20 wt% bLF-PLLA membrane 
was even able to induce cell proliferation after 24 h of indirect contact. Although not 
displaying a relevant antimicrobial activity against the bacteria tested, the composite 
membranes showed to be highly effective against the filamentous fungi A. nidulans. Indeed, 
the bLF-PLLA membranes showed to exert a strong sporicidal activity, as well as mycelium 
growth inhibition, against A. nidulans. Overall, the obtained results strongly support the 
application of these membranes for biomedical applications especially, for fungal infections 
management.  
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Figure 1. Morphology of bLF-PLA electrospun membranes with different bLF content: a) 0 
wt%, b) 10 wt%, c) 20 wt%, and d) average fibre diameter and water contact angle (WCA). 
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Figure 2. a) Fourier transformed infrared spectra of PLLA, bLF and bLF-PLLA electrospun 
membranes with 10 and 20 wt% of bLF, b) normalized spectra in the amide I (1700-1600 cm-
1) and amide II (1500-1400 cm-1) band regions. 
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Figure 3. Differential scanning calorimetry of bLF-PLLA electrospun membranes. 
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Figure 4. a) Thermal degradation profile of bLF-PLLA samples recorded at 20 °C.min-1, b) 
derivative of the thermal degradation process (heating rate 20 °C.min-1), c) plots of the 
activation energy of the degradation process according to Kissinger model, and d) evolution 
of the activation energy with the concentration of the bLF in the different bLF-PLLA samples. 
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Figure 5. Hydrolytic degradation of electrospun composites (20 wt%) in PBS (pH 7.4) at 37 
ºC (a); release profile of bLF and linear fitting using Korsmeyer-Peppas model (b). 
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Figure 6. Cytotoxicity evaluation of bLF-PLLA electrospun membranes with different bLF 
contents (0 wt%, 10 wt%, and 20 wt%). Indirect contact assay was performed on normal 
human skin fibroblasts (BJ-5ta cell line) using the MTS assay and represented as % cell 
viability in relation to the control. Bars represent mean ± SD (ns, nonsignificant; *p < 0.05, 
**p < 0.01 and ****p < 0.0001). 
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Figure 7. Antimicrobial activity of bLF-PLLA electrospun membranes (0 wt%, 10 wt%, and 
20 wt%. a) Disk diffusion assay against P. aeruginosa and S. aureus in an agar layer for 18 h 
at 37 ºC. b) SEM micrographs of germinating spores of A. nidulans in contact with the 
electrospun membranes for 18 h at 37 ºC; scale bar: 20 μm. c) A. nidulans mycelial growth in 
contact with (1) itraconazol impregnated disk (25 mg/mL), (2) 0 wt% bLF-PLLA, (3) no 
sample, and (4) 20 wt% bLF-PLLA; inoculation site without any sample was used as control 
for mycelium growth; bars represent means ± SD (ns, nonsignificant, ****p ≤ 0.0001; 
experiments were performed in triplicate. 
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Bovine lactoferrin, an iron-biding glycoprotein displays a wide set of physiological roles 
including a strong antimicrobial activity. The development of antimicrobial membranes by 
incorporating bovine lactoferrin in a poly(lactic acid) matrix is reported. The membranes 
show a strong sporicidal activity and mycelium growth inhibition against the filamentous 
fungi A. nidulans. These results strongly support their application for fungal infections 
management. 
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Table S1. Electrospinning parameters used for the preparation of PLLA and bLF-PLLA 
membranes. 
Parameters Optimal conditions for electrospinning 
Applied electric field 1.0 kV.cm-1 
Flow rate 0.5 mL.min-1 
Needle inner diameter 0.5 mm 
Polymer concentration 10 % (w/v) 
 
 
Table S2. Thermal properties and degree of crystallinity for the bLF-PLLA electrospun 
membranes.  
bLF content 
(wt%) 
Tg 
(ºC) 
Tcc 
(ºC) 
Tm 
(ºC) 
∆Hm 
(J.g-1) 
Cp 
(J.g-1.K-1) 
0 57 86 154 37 0.54 
10 57 86 154 31 0.44 
20 57 * 154 28 0.40 
* - suppressed by bLF; Tg – glass transistion; Tcc – cold-crystallization temperature; 
Tm – melting temperature; ∆Hm – Melting enthalpy; Cp – heat capacity at constant 
pressure. 
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Table S3. Initial degradation, onset temperatures and activation energy of the bLF-PLLA 
electrospun samples. 
bLF content 
(wt%) 
Tinitial 
(ºC) 
Tonset 
(ºC) 
Residual mass at 500ºC 
(%) 
0 235 335 1 
10 223 327 4 
20 213 320 9 
100 201 269 30 
 
 
 
 
 
